Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Carcinoid tumors of the urinary tract and prostate.

Murali R, Kneale K, Lalak N, Delprado W.

Arch Pathol Lab Med. 2006 Nov;130(11):1693-706. Review.

PMID:
17076534
2.

Primary carcinoid tumors of the urinary bladder and prostatic urethra: a clinicopathologic study of 6 cases.

Chen YB, Epstein JI.

Am J Surg Pathol. 2011 Mar;35(3):442-6. doi: 10.1097/PAS.0b013e318208f96a.

PMID:
21317716
3.

Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.

Higgins JP, Kaygusuz G, Wang L, Montgomery K, Mason V, Zhu SX, Marinelli RJ, Presti JC Jr, van de Rijn M, Brooks JD.

Am J Surg Pathol. 2007 May;31(5):673-80.

PMID:
17460449
4.

[Non-urothelial tumors of the urinary tract].

Mikuz G.

Verh Dtsch Ges Pathol. 1993;77:180-98. Review. German.

PMID:
7511278
5.

Clear cell neoplasms of the urinary tract and male reproductive system.

Humphrey PA.

Semin Diagn Pathol. 1997 Nov;14(4):240-52. Review.

PMID:
9383824
6.

Risk of second cancers in patients with colorectal carcinoids.

Tichansky DS, Cagir B, Borrazzo E, Topham A, Palazzo J, Weaver EJ, Lange A, Fry RD.

Dis Colon Rectum. 2002 Jan;45(1):91-7.

PMID:
11786770
7.

Oat cell carcinoma of the urinary tract. An immunohistochemical and electron microscopic study.

Ordóñez NG, Khorsand J, Ayala AG, Sneige N.

Cancer. 1986 Dec 1;58(11):2519-30.

9.

Thrombomodulin expression in transitional cell carcinoma.

Ordóñez NG.

Am J Clin Pathol. 1998 Sep;110(3):385-90.

PMID:
9728615
10.

Incidental ileal carcinoid associated with multiple urologic malignancies.

Adams JR Jr, Culkin DJ, Mata JA, Venable DD.

J La State Med Soc. 1991 Aug;143(8):27-9.

PMID:
1940565
11.

[Tumor markers in the histopathology of urologic tumors].

Hofstädter F.

Urologe A. 1987 Jan;26(1):2-6. German.

PMID:
3576859
12.

Calcitonin-producing well-differentiated neuroendocrine carcinoma (carcinoid tumor) of the urinary bladder: case report.

Mascolo M, Altieri V, Mignogna C, Napodano G, De Rosa G, Insabato L.

BMC Cancer. 2005 Jul 27;5:88.

13.
14.

Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumors.

Li SL, Goko H, Xu ZD, Kimura G, Sun Y, Kawachi MH, Wilson TG, Wilczynski S, Fujita-Yamaguchi Y.

Cell Tissue Res. 1998 Mar;291(3):469-79.

PMID:
9477303
15.
16.

Diagnosis of carcinoid-like metastatic prostatic carcinoma by an immunoperoxidase method.

Ansari MA, Pintozzi RL, Choi YS, Ladove RF.

Am J Clin Pathol. 1981 Jul;76(1):94-8.

PMID:
7020410
17.

Unusual prostatic carcinomas.

Dhom G.

Pathol Res Pract. 1990 Feb;186(1):28-36. Review.

PMID:
2179908
18.

Grading and prognostic significance of urologic carcinomas.

Helpap B.

Urol Int. 1992;48(3):245-57. Review.

PMID:
1589911
19.

Clear cell carcinoma of the lower urinary tract in a male patient. Presentation and update on histogenesis and management.

Tyritzis SI, Anastasiou I, Petrolekas A, Alevizopoulos A, Mitropoulos D, Constantinides CA.

Pathol Int. 2009 Aug;59(8):595-7. doi: 10.1111/j.1440-1827.2009.02413.x. No abstract available.

PMID:
19627546

Supplemental Content

Support Center